This book presents current research in the study of various cancer treatments. Topics discussed include anticancer drugs and anticancer agents; design of novel anticancer drugs; aromatase inhibitors; aromatase inhibitors for the medical treatment of endometriosis; the use of aromatase inhibitors in ovarian cancer and identification of responsive tumours; inherent and microenvironment-mediated mechanisms of drug resistance; targeting adverse features of hormone-resistant breast cancer; systematic analysis of patterns of cross resistance between anticancer agents and treating drug resistant malignancy.
Preface; Micro- & Nano-Particulate Drug Delivery Systems for Cancer Treatment; Geldanamycin Derivatives as Promising Anticancer Drugs:: Therapy via Hsp90 Inhibition; Synergistic Antitumor Activity of Metronomic Dosing Chemotherapy in Combination with Liposomal Anticancer Drug; Organotin Polyethers as Anticancer Drugs; Studies on Anticancer Agents:: Phenolic Compounds & their Pharmacological Activity; Design of Novel Anticancer Drugs Utilizing Busulfan for Optimizing Pharmacological Properties & Pattern Recognition Techniques for Elucidation of Clinical Efficacy; Analysis of Associations Among Novel Property Descriptors & their Capacity in Determining Clinical Efficacy by Utilizing Pattern Recognition Technigues ; Insights into the Mode of Action of Investigational Ruthenium(III) Cytotoxins from Electrochemical & Biological Studies; Marina Crystal Minerals(MCM) Induce Apoptosis of Human Metastatic Breast Cancer MDA-MB-231 Cells In Vitro; Anti-Estrogen Agents:: Aromatase Inhibitors; Past, Present & Future; Aromatase Inhibitors:: Types, Mode of Action & Indications; Aromatase Inhibitors.
Comments (0)
Your review appreciation cannot be sent
Report comment
Are you sure that you want to report this comment?
Report sent
Your report has been submitted and will be considered by a moderator.